PUBLISHER: The Business Research Company | PRODUCT CODE: 1955477
PUBLISHER: The Business Research Company | PRODUCT CODE: 1955477
Inactivated Vaccines Global Market Report 2026
Inactivated vaccines, sometimes called killed vaccines, are vaccines made from viruses or bacteria that have been rendered inactive through methods such as heat, chemicals, or radiation. These vaccines aim to trigger an immune response while not causing illness in the person receiving the vaccine.
The primary categories of inactivated vaccines include viral and bacterial vaccines. A viral vaccine is a biological formulation that contains weakened or inactivated viral components to activate the immune system and confer protection against a specific viral infection. These vaccines may be inactivated using techniques such as solvent detergents, radiation, pH adjustment, heat treatment, and other methods, and they are distributed through hospital pharmacies, retail pharmacies, and other channels.
Tariffs have affected the inactivated vaccines market by increasing import costs for raw materials, adjuvants, and specialized manufacturing equipment, particularly in regions dependent on global supply chains such as Asia-Pacific and Europe. Vaccine production segments like viral and bacterial vaccines are most impacted due to reliance on imported components. While tariffs may increase costs and slow production, they could also encourage local manufacturing investments and regional production hubs, fostering self-reliance in vaccine supply.
The inactivated vaccines market research report is one of a series of new reports from The Business Research Company that provides inactivated vaccines market statistics, including inactivated vaccines industry global market size, regional shares, competitors with a inactivated vaccines market share, detailed inactivated vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the inactivated vaccines industry. This inactivated vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The inactivated vaccines market size has grown steadily in recent years. It will grow from $6.37 billion in 2025 to $6.61 billion in 2026 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to rising incidence of infectious diseases, advancements in virology research, government funding for immunization, expansion of healthcare infrastructure, public awareness campaigns for vaccination.
The inactivated vaccines market size is expected to see strong growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing geriatric population, growth in emerging markets healthcare access, technological advancements in vaccine delivery systems, rise in global immunization initiatives, adoption of multi-dose and combination vaccines. Major trends in the forecast period include advancements in vaccine formulation, expansion of cold chain logistics, increasing demand for pediatric vaccines, growth in government immunization programs, development of combination vaccines.
The rising incidence of infectious diseases is anticipated to drive the expansion of the inactivated vaccine market in the coming years. Infectious diseases are conditions caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread between individuals, leading to a broad spectrum of symptoms and potential health complications. Tuberculosis represents one such infectious disease. Inactivated vaccines contain non-living pathogens that trigger an immune response, helping to prevent illnesses such as polio, hepatitis A, and influenza. For instance, in November 2023, data published by the Centers for Disease Control and Prevention, a US-based national public health agency, showed that the number of tuberculosis cases in the United States rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Therefore, the growing prevalence of infectious diseases is contributing to the growth of the inactivated vaccine market.
Major companies operating in the inactivated vaccines market are prioritizing new product launches and regulatory approvals to reinforce their global vaccine portfolios and address increasing immunization demand. For instance, in April 2024, Sanofi S.A., a France-based healthcare company, launched Verorab, its inactivated rabies vaccine, in the UK for use in individuals of all age groups for both pre-exposure and post-exposure prevention. This introduction underscores the company's continued efforts to broaden its inactivated vaccine offerings and enhance its global immunization presence. The development also reflects growing investments and regulatory support for inactivated vaccine research and approvals. As more companies pursue similar strategies and expand their product lines, these initiatives are collectively fueling notable growth in the inactivated vaccines market and supporting broader protection against infectious diseases.
In October 2024, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Bharat Serums & Vaccines Limited (BSV) for an undisclosed sum. Through this acquisition, Mankind Pharma sought to enter high-barrier biologics and vaccine manufacturing, including capabilities in conventional inactivated vaccines, thereby diversifying and strengthening its product portfolio. Bharat Serums & Vaccines is an India-based biopharmaceutical firm engaged in the development, manufacturing, and marketing of recombinant biologics, complex injectables, and vaccines, including those based on inactivated virus technology.
Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.
North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the inactivated vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The inactivated vaccines market consists of sales of whole-cell inactivated vaccines, subunit or protein subunit vaccines, conjugate vaccines and toxoid vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Inactivated Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses inactivated vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for inactivated vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The inactivated vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
- Markets Covered:1) By Type: Viral Vaccine; Bacterial Vaccine
- 2) By Method Of Inactivation: Solvent Detergent; Radiation; pH Concentration; Heat Inactivation; Other Methods Of Inactivation
- 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
- Subsegments:
- 1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV); Inactivated Influenza Vaccine; Inactivated Hepatitis A Vaccine; Inactivated Rabies Vaccine
- 2) By Bacterial Vaccine: Inactivated Typhoid Vaccine; Inactivated Cholera Vaccine; Inactivated Pertussis Vaccine; Inactivated Plague Vaccine
- Companies Mentioned: Pfizer Inc.; Sinopharm Group Co. Ltd.; Merck & Co. Inc.; Sanofi S.A.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; CSL Limited; Daiichi Sankyo Company Limited; Zydus Lifesciences Ltd.; Sinovac Biotech Ltd.; Biological E Limited; Hualan Biological Engineering Inc.; Shenzhen Kangtai Biological Products Co. Ltd.; Serum Institute of India Pvt. Ltd.; Beijing Tiatan Biological Products Co. Ltd.; Valneva SE; Beijing Minhai Biotechnology Co. Ltd.; Bharat Biotech International Limited; Panacea Biotec Ltd.; Sinergium Biotech SA; Bharat Immunologicals and Biologicals Corporation Limited; Haffkine Biopharmaceutical Corporation Limited; Incepta Vaccine Ltd.; Changchun BCHT Biotechnology Co. Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: Word, PDF or Interactive Report
- + Excel Dashboard
- Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
Table of Contents
1. Executive Summary
- 1.1. Key Market Insights (2020-2035)
- 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
- 1.3. Major Factors Driving the Market
- 1.4. Top Three Trends Shaping the Market
2. Inactivated Vaccines Market Characteristics
- 2.1. Market Definition & Scope
- 2.2. Market Segmentations
- 2.3. Overview of Key Products and Services
- 2.4. Global Inactivated Vaccines Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
- Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
- 2.4.4. Market Attractiveness Scoring and Interpretation
- 2.4.5. Strategic Implications and Recommendations
3. Inactivated Vaccines Market Supply Chain Analysis
- 3.1. Overview of the Supply Chain and Ecosystem
- 3.2. List Of Key Raw Materials, Resources & Suppliers
- 3.3. List Of Major Distributors and Channel Partners
- 3.4. List Of Major End Users
4. Global Inactivated Vaccines Market Trends And Strategies
- 4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.2. Major Trends
- 4.2.1 Advancements In Vaccine Formulation
- 4.2.2 Expansion Of Cold Chain Logistics
- 4.2.3 Increasing Demand For Pediatric Vaccines
- 4.2.4 Growth In Government Immunization Programs
- 4.2.5 Development Of Combination Vaccines
5. Inactivated Vaccines Market Analysis Of End Use Industries
- 5.1 Hospitals
- 5.2 Clinics
- 5.3 Government Immunization Programs
- 5.4 Research Laboratories
- 5.5 Retail Pharmacies
6. Inactivated Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Inactivated Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
- 7.1. Global Inactivated Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 7.2. Global Inactivated Vaccines Market Size, Comparisons And Growth Rate Analysis
- 7.3. Global Inactivated Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
- 7.4. Global Inactivated Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Inactivated Vaccines Total Addressable Market (TAM) Analysis for the Market
- 8.1. Definition and Scope of Total Addressable Market (TAM)
- 8.2. Methodology and Assumptions
- 8.3. Global Total Addressable Market (TAM) Estimation
- 8.4. TAM vs. Current Market Size Analysis
- 8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Inactivated Vaccines Market Segmentation
- 9.1. Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Viral Vaccine, Bacterial Vaccine
- 9.2. Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
- 9.3. Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
- 9.4. Global Inactivated Vaccines Market, Sub-Segmentation Of Viral Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
- 9.5. Global Inactivated Vaccines Market, Sub-Segmentation Of Bacterial Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
10. Inactivated Vaccines Market Regional And Country Analysis
- 10.1. Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- 10.2. Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Inactivated Vaccines Market
- 11.1. Asia-Pacific Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Inactivated Vaccines Market
- 12.1. China Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 12.2. China Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Inactivated Vaccines Market
- 13.1. India Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Inactivated Vaccines Market
- 14.1. Japan Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 14.2. Japan Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Inactivated Vaccines Market
- 15.1. Australia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Inactivated Vaccines Market
- 16.1. Indonesia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Inactivated Vaccines Market
- 17.1. South Korea Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 17.2. South Korea Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Inactivated Vaccines Market
- 18.1. Taiwan Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 18.2. Taiwan Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Inactivated Vaccines Market
- 19.1. South East Asia Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 19.2. South East Asia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Inactivated Vaccines Market
- 20.1. Western Europe Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 20.2. Western Europe Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Inactivated Vaccines Market
- 21.1. UK Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Inactivated Vaccines Market
- 22.1. Germany Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Inactivated Vaccines Market
- 23.1. France Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Inactivated Vaccines Market
- 24.1. Italy Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Inactivated Vaccines Market
- 25.1. Spain Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Inactivated Vaccines Market
- 26.1. Eastern Europe Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 26.2. Eastern Europe Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Inactivated Vaccines Market
- 27.1. Russia Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Inactivated Vaccines Market
- 28.1. North America Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 28.2. North America Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Inactivated Vaccines Market
- 29.1. USA Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 29.2. USA Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Inactivated Vaccines Market
- 30.1. Canada Inactivated Vaccines Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 30.2. Canada Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Inactivated Vaccines Market
- 31.1. South America Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 31.2. South America Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Inactivated Vaccines Market
- 32.1. Brazil Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Inactivated Vaccines Market
- 33.1. Middle East Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 33.2. Middle East Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Inactivated Vaccines Market
- 34.1. Africa Inactivated Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 34.2. Africa Inactivated Vaccines Market, Segmentation By Type, Segmentation By Method Of Inactivation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Inactivated Vaccines Market Regulatory and Investment Landscape
36. Inactivated Vaccines Market Competitive Landscape And Company Profiles
- 36.1. Inactivated Vaccines Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
- 36.2. Inactivated Vaccines Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
- 36.3. Inactivated Vaccines Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Sinopharm Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
37. Inactivated Vaccines Market Other Major And Innovative Companies
- Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA
38. Global Inactivated Vaccines Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Inactivated Vaccines Market
40. Inactivated Vaccines Market High Potential Countries, Segments and Strategies
- 40.1 Inactivated Vaccines Market In 2030 - Countries Offering Most New Opportunities
- 40.2 Inactivated Vaccines Market In 2030 - Segments Offering Most New Opportunities
- 40.3 Inactivated Vaccines Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies
41. Appendix
- 41.1. Abbreviations
- 41.2. Currencies
- 41.3. Historic And Forecast Inflation Rates
- 41.4. Research Inquiries
- 41.5. The Business Research Company
- 41.6. Copyright And Disclaimer
